European Pharmaceutical Review

FEBRUARY 10, 2023

Changes to management for Big Pharma companies Astellas and Bayer AG have been announced for 2023. Astellas Astellas Pharma Inc. Kenji Yasukawa, present Representative Director, President and CEO of Astellas, will be Representative Director, Chairman of the Board following the change.

Management 101

Management Engineering Pharma Leads 101

European Pharmaceutical Review

MAY 2, 2023

Astellas Pharma has agreed to acquire ophthalmology biotech company Iveric Bio, Inc. Under the agreement, Astellas will accelerate clinical development and commercialisation of treatments for conditions such as geographic atrophy (GA). billion in 2028, according to GlobalData’s Pharma Intelligence Center.

Food and Drug Administration 52

Food and Drug Administration Pharma FDA Sales 52

European Pharmaceutical Review

AUGUST 8, 2022

Eight years after the whistle was blown on Eli Lilly for allegedly underpaying the rebates required of drug manufacturers under the US Medicaid Drug Rebate Program, a jury has ordered the company to pay more than $61 million in damages. Takeda Pharmaceuticals America, Inc. agreements with AstraZeneca ($46.5 million) and Cephalon ($7.5

Manufacturing 89

Manufacturing Pharmaceutical Pharma Leads 89

PM360

SEPTEMBER 23, 2022

The awards recognize outstanding companies, CEOs, products, marketers, brand managers, and cutting-edge initiatives within the pharmaceutical, biotech, medical device, and diagnostics industries. COMPANY OF THE YEAR: PHARMACEUTICAL/BIOTECH. COMPANY OF THE YEAR: MEDICAL DEVICE/DIAGNOSTICS. COMPANY OF THE YEAR: ADVERTISING AGENCY.

Education 98

Education Marketing Pharmaceutical Medical 98

PM360

AUGUST 17, 2022

Top Companies, Marketers, CEOs, Products, and Initiatives to be Honored During Gala on September 22 nd . To reach the finalist phase, Companies must show achievement in various areas including innovation, talent development, and social responsibility. For immediate release . Contact: Andrew Matthius. Senior Editor, PM360.

Marketing 52

Marketing Healthcare Healthcare Education 52

Clarivate

MAY 8, 2024

As companies face the prospect of major revenue challenges over the next few years, securing inorganic growth through strategic alliances is increasingly attractive. This time, the company paid top dollar for ADCs targeting solid tumors from Daiichi Sankyo, with the value of this single deal equaling all of its 15 deals in 2022.

Pharma 59

Pharma Biopharma Prospecting Competition 59

European Pharmaceutical Review

OCTOBER 12, 2023

The pharmaceutical company stated it will establish the first industrial-scale supply of biomethane. AstraZeneca’s facilities in Macclesfield, the UK’s largest pharma manufacturing site, as well as Cambridge, Luton and Speke will all be supplied by energy from the new facility, which is currently being built. Kerry, Ireland.

Pharmaceutical manufacturing 85

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 85